KLK3 and pachyonychia congenita: They recommended that overuse of PC screening and active treatment for low-risk localized PC (such as < PSA ng/dL) be avoided so that TPL surgery can be performed without wasting time waiting for 2–5 years to attain a cancer-free status, considering most patients (about 70%) on hemodialysis die within 5 years [29].